# SUCRALFATE
> **ANDA216474** · Abbreviated New Drug Application (Generic) · Sponsor: STRIDES PHARMA · Approved 2024-05-21
## Drug
- **FDA Application Number:** ANDA216474
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUCRALFATE
- **Generic name:** SUCRALFATE
- **Active ingredients:** SUCRALFATE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** STRIDES PHARMA
- **Manufacturer:** Strides Pharma Science Limited
- **First approval:** 2024-05-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216474)
---
*AI Analytics · CC0 1.0*